Wang, Ruiwei <br/><br/>
Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway.  [electronic resource] 

 -  Drug design, development and therapy  2019 
 - 501-512 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1177-8881 
<br/><br/><label>Standard No.: </label>10.2147/DDDT.S188636  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain--drug effects<br/>Dose-Response Relationship, Drug<br/>Female<br/>Glycogen Synthase Kinase 3 beta--metabolism<br/>Isoflurane--pharmacology<br/>Ketamine--pharmacology<br/>Male<br/>Neurocognitive Disorders--chemically induced<br/>Neuroprotective Agents--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction--drug effects